The c-Myc target gene network

Cited by (1,000)

Items 201–300 of 1,000

1. Circular RNA PVT1 Expression and its Roles in Acute Lymphoblastic Leukemia
   Jiaojiao Hu, Qi Han, Yan Gu, Jinlong Ma, Mary McGrath, Fengchang Qiao, Baoan Chen, Chunhua Song, Zheng Ge · 2018 · Epigenomics
2. MYC, FBXW7 and TP53 copy number variation and expression in Gastric Cancer
   Danielle Queiroz Calcagno, Vanessa M. Freitas, Mariana Ferreira Leal, Carolina Rosal Teixeira de Souza, Sâmia Demachki, Raquel Carvalho Montenegro, Paulo Pimentel de Assumpção, André Salim Khayat, Marı́lia de Arruda Cardoso Smith, Ândrea Ribeiro‐dos‐Santos et al. · 2013 · BMC Gastroenterology
3. Antagonism between FOXO and MYC Regulates Cellular Powerhouse
   Barrie Peck, Emma C. Ferber, Almut Schulze · 2013 · Frontiers in Oncology
4. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion
   Natasha M. Rogers, Zheng Jenny Zhang, Jiao-Jing Wang, Angus W. Thomson, Jeffrey Scott Isenberg · 2016 · Kidney International
5. Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
   Phuoc Tho Tran, Alice C. Fan, Pavan K. Bendapudi, Shan Koh, K.M. Komatsubara, Joy Chen, George Horng, David I. Bellovin, Sylvie Giuriato, Craig S. Wang et al. · 2008 · PLoS ONE
6. Burkitt Lymphoma: Pathogenesis and Immune Evasion
   Jason M. God, A. Haque · 2010 · Journal of Oncology
7. Non-canonical progesterone signaling in granulosa cell function
   John J. Peluso, James K. Pru · 2014 · Reproduction
8. Pharmacological manipulation of transcription factor protein-protein interactions: opportunities and obstacles
   Frank R. Fontaine, Jeroen Paardekooper Overman, Mathias François · 2015 · Cell Regeneration
9. The Hippo Pathway in Prostate Cancer
   Omar Salem, Carsten Gram Hansen · 2019 · Cells
10. Down-regulation of Myc Is Essential for Terminal Erythroid Maturation
    Senthil Raja Jayapal, Kian Leong Lee, Peng Ji, Philipp Kaldis, Bing Lim, Harvey F. Lodish · 2010 · Journal of Biological Chemistry
11. Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
    Xiao-Na Pan, Jia-Jie Chen, Le-Xun Wang, Ruo-Zhi Xiao, Ling-Ling Liu, Zhi-Gang Fang, Quentin Liu, Zi‐Jie Long, Dong-Jun Lin · 2014 · PLoS ONE
12. c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma
    Hui Luo, Zhengxin Chen, Shuai Wang, Rui Zhang, Wenjin Qiu, Lin Zhao, Chenghao Peng, Ran Xu, Wanghao Chen, Hongwei Wang et al. · 2015 · Brain
13. CCAT1: an oncogenic long noncoding RNA in human cancers
    Xiaoqiang Guo, Yuming Hua · 2016 · Journal of Cancer Research and Clinical Oncology
14. MYC Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh2 Methyltransferase
    Mandeep Kaur, Michael D. Cole · 2012 · Cancer Research
15. ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc
    Chun Zhang, Shuping Zhang, Z Zhang, Jiuyang He, Yong Xu, Sijin Liu · 2013 · Oncogene
16. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8
    Shuvomoy Banerjee, Jie Li Lu, Qiliang Cai, Abhik Saha, Hem Chandra Jha, Richard Kuo Dzeng, Erle S. Robertson · 2013 · PLoS Pathogens
17. A therapeutic role for targeting c-Myc/Hif-1- dependent signaling pathways
    Klaus Podar, Kenneth Carl Anderson · 2010 · Cell Cycle
18. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia
    Mélanie Bonnet, Marie Loosveld, Bertrand Montpellier, Jean‐Marc Navarro, Benoît Quilichini, Christophe Picard, Julie Di Cristofaro, Claude Bagnis, Chantal Fossat, Lucie Hernandez et al. · 2011 · Blood
19. MYC, microRNAs and glutamine addiction in cancers
    Chi Van Dang · 2009 · Cell Cycle
20. Distinct transcriptional regulatory modules underlie STAT3’s cell type-independent and cell type-specific functions
    Andrew P. Hutchins, Diego Díez, Yoshiko Takahashi, Shandar Ahmad, Ralf Jauch, Michel L. Tremblay, Diego Miranda‐Saavedra · 2013 · Nucleic Acids Research
21. Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer Cells
    Aydee C. Estrada, Tatiana Syrovets, Kai Pitterle, Oleg Lunov, Berthold Büchele, Judith Schimana-Pfeifer, Thomas Jürgen Schmidt, Samy A.F. Morad, Thomas Simmet · 2009 · Molecular Pharmacology
22. Current Status of Long Non-Coding RNAs in Human Breast Cancer
    Stefanie Cerk, Daniela Schwarzenbacher, Jan Basri Adiprasito, Michael Stotz, Georg C. Hutterer, Armin Gerger, Hui Yvonne Ling, George A. Călin, Martin Pichler · 2016 · International Journal of Molecular Sciences
23. Suppression of pyruvate dehydrogenase kinase-2 re-sensitizes paclitaxel-resistant human lung cancer cells to paclitaxel
    Hong Sun, An-You Zhu, Xiang Zhou, Fengchao Wang · 2017 · Oncotarget
24. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases
    Ferenc Sípos, Gábor Firneisz, Györgyi Műzes · 2016 · World Journal of Gastroenterology
25. BRD4 and MYC : power couple in transcription and disease
    Aparna Kotekar, Amit Kumar Singh, Ballachanda N. Devaiah · 2022 · FEBS Journal
26. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
    Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, Laura Soucek · 2024 · Signal Transduction and Targeted Therapy
27. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors
    Michael D. Cole, Victoria H. Cowling · 2009 · Oncogene
28. c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
    Kristin L. Robinson, Nichaya Asawachaicharn, Denise A. Galloway, Carla Grandori · 2009 · PLoS ONE
29. Prognostic value of MYC rearrangement in cases of B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and Burkitt lymphoma
    Pei Lin, Timothy J. Dickason, Luis Fayad, Patrick A. Lennon, Peter C. Hu, Mar Garcia, Mark J. Routbort, Roberto N. Miranda, Xumei Wang, Wei Qiao et al. · 2011 · Cancer
30. Chlorpyrifos is estrogenic and alters embryonic hatching, cell proliferation and apoptosis in zebrafish
    Kaimin Yu, Guochao Li, Weimin Feng, Lili Liu, Jiayu Zhang, Wei Wu, Lei Xu, Yanchun Yan · 2015 · Chemico-Biological Interactions
31. c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling
    Yang Shen, Naijun Miao, Bao Wang, Jinlan Xu, Xinxin Gan, Dan Xu, Li Zhou, Hong Xue, Wei Zhang, Li Yang et al. · 2017 · Kidney International
32. USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
    Jianchao Ge, Wandong Yu, Junhong Li, Hangbin Ma, Pengyu Wang, Yinghao Zhou, Yang Wang, Jun Zhang, Guowei Shi · 2021 · Journal of Experimental & Clinical Cancer Research
33. Current Status and Prospects of Targeted Therapy for Osteosarcoma
    Zunguo Hu, Shuang Wen, Zijun Huo, Qing Wang, Jiantao Zhao, Zihao Wang, Yanchun Chen, Lingyun Zhang, Fenghua Zhou, Zhangyu Guo et al. · 2022 · Cells
34. The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma
    Sonali M. Smith, John Anastasi, Kenneth Stuart Cohen, Lucy A. Godley · 2010 · Blood Cells Molecules and Diseases
35. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
    Koichiro Kawaguchi, Ayumi Kinameri, Shunsuke Suzuki, Shogo Senga, Youqiang Ke, Hiroshi Fujii · 2015 · Biochemical Journal
36. Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses
    Imelda Martínez-Ramírez, Adela Carrillo‐García, Adriana Contreras‐Paredes, Elizabeth Ortíz-Sánchez, Alfredo Cruz‐Gregorio, Marcela Lizano · 2018 · International Journal of Molecular Sciences
37. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways
    Tianli Chen, Kangshuai Li, Zengli Liu, Jialiang Liu, Yue Wang, Rongqi Sun, Zhipeng Li, Bo Qiu, Xiaoming Zhang, Guangli Ren et al. · 2021 · Molecular Therapy
38. Myc: The Beauty and the Beast
    Amanda R. Wasylishen, Linda Z. Penn · 2010 · Genes & Cancer
39. Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy
    Aishwarya L. Saraswat, Hari Priya Vemana, Vikas V. Dukhande, Ketan R. Patel · 2022 · Heliyon
40. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors
    Patrizia Cancemi, Miriam Buttacavoli, Elena Roz, Salvatore Feo · 2019 · International Journal of Molecular Sciences
41. Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
    Ji Tae Kim, Chang Li, Heidi L. Weiss, Yuning Zhou, Chunming Liu, Qingding Wang, Bernard Mark Evers · 2019 · Cells
42. Policing Cancer: Vitamin D Arrests the Cell Cycle
    Sachin Bhoora, Rivak Punchoo · 2020 · International Journal of Molecular Sciences
43. c-Myc modulates microRNA processing via the transcriptional regulation of Drosha
    Xingwu Wang, Xiaocheng Zhao, Ping Gao, Mian Wu · 2013 · Scientific Reports
44. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
    Marco Gallo, Giovanna Muscogiuri, Francesco Felicetti, Antongiulio Faggiano, Francesco Trimarchi, Emanuela Arvat, Riccardo Vigneri, Annamaria Colao · 2017 · Metabolism
45. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver
    Karen R. Reed, Dimitris Athineos, Valérie S. Méniel, Julie A. Wilkins, Rachel A. Ridgway, Zoë D. Burke, Vanesa Muncan, Alan Richard Clarke, Owen James Sansom · 2008 · Proceedings of the National Academy of Sciences
46. Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
    Chan Joo Yeom, Yökö Gotö, Yuxi Zhu, Masahiro Hiraoka, Hiroshi Harada · 2012 · International Journal of Molecular Sciences
47. Metabolic Reprogramming in Thyroid Carcinoma
    Raquel Guimarães Coelho, Rodrigo S. Fortunato, Denise Pires de Carvalho · 2018 · Frontiers in Oncology
48. Mast cell‐based molecular subtypes and signature associated with clinical outcome in early‐stage lung adenocarcinoma
    Xuanwen Bao, Run Shi, Tianyu Zhao, Yanfang Wang · 2020 · Molecular Oncology
49. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities
    Carina Neitzel, Philipp Demuth, Simon Wittmann, Jörg Fahrer · 2020 · Cancers
50. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis
    Philip D. Anderson, Sydika A. McKissic, Monica Logan, Meejeon Roh, Omar E. Franco, Jie Wang, Irina Doubinskaia, Riet van der Meer, Simon W. Hayward, Christine M. Eischen et al. · 2012 · Journal of Clinical Investigation
51. Expression of Metabolic, Tissue Remodeling, Oxidative Stress, and Inflammatory Pathways in Mammary Tissue during Involution in Lactating Dairy Cows
    Paola Piantoni, Ping Wang, James Kent Drackley, W.L. Hurley, Juan J. Loor · 2010 · Bioinformatics and Biology Insights
52. c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
    Jens Rauch, Kim Moran‐Jones, Valerie S. Albrecht, Thomas Schwarzl, Keith David Hunter, Olivier Gires, Walter Kölch · 2011 · Cancer Research
53. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
    Jennifer F. Barger, David R. Plas · 2010 · Endocrine Related Cancer
54. Small molecules targeting protein–protein interactions for cancer therapy
    Wu, Defa, Li, Yang, Zheng, Lang, Xiao, Huan, Ouyang, Liang, Wang, Guan, Sun, Qiu · 2023 · Acta Pharmaceutica Sinica B
55. Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection
    Anil Pant, Lara Dsouza, Zhilong Yang · 2021 · mBio
56. SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer
    Liu, Lei, Zhang, Jing, Yang, Xiaoming, Fang, Chi, Xu, Huali, Xi, Xiaowei · 2015 · PLOS ONE · Retracted
57. DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis
    Mrinal Y. Shah, Aparna Vasanthakumar, Natalie Y. Barnes, María E. Figueroa, Anna Kamp, Christopher Hendrick, Kelly R. Ostler, Elizabeth M. Davis, Shang Lin, John Anastasi et al. · 2010 · Cancer Research
58. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
    Cheng Yeh Chen, Shaoxin Cai, Guihua Wang, Xiaonian Cao, Xi Yang, Xuelai Luo, Yongdong Feng, Junbo Hu · 2012 · Biochemical and Biophysical Research Communications
59. Long Noncoding RNA DANCR Is a Positive Regulator of Proliferation and Chondrogenic Differentiation in Human Synovium-Derived Stem Cells
    Lei Zhang, Chao Yang, Shuo Chen, Guihua Wang, Ben Shi, Xin Tao, Liwu Zhou, Jianning Zhao · 2016 · DNA and Cell Biology
60. Sperm-borne miR-449b influences cleavage, epigenetic reprogramming and apoptosis of SCNT embryos in bovine
    Mengyun Wang, Yang Gao, Pengxiang Qu, Suzhu Qing, Fang Qiao, Yong Zhang, Jesse Mager, Yongsheng Wang · 2017 · Scientific Reports
61. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways
    Xujuan Sun, Shuqing Liu, Jinxia Wang, Bin Wei, Chunmei Guo, Chen Chen, Ming‐Zhong Sun · 2018 · Cell Death and Disease
62. Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
    Rebecca Lamb, Hannah Harrison, Duncan L. Smith, Paul A. Townsend, Thomas Jackson, Béla Ózsvári, Ubaldo Martinez‐Outschoorn, Richard G. Pestell, Anthony Howell, Michael P. Lisanti et al. · 2015 · Oncotarget
63. Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
    Chi Van Dang · 2010 · Genes & Cancer
64. Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein
    Bharat G. Bajaj, Masanao Murakami, Qiliang Cai, Subhash Chandra Verma, Ke Lan, Erle S. Robertson · 2008 · Journal of Virology
65. Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia
    Sobia Rana, Mustafa Ahmad Munawar, Adeela Shahid, Meera Malik, Hafeez Ullah, Warda Fatima, Shahida Mohsin, Saqib Mahmood · 2013 · Molecular Biology Reports
66. Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
    Yasmin Dekker, Sylvia E. Le Dévédec, Erik H.J. Danen, Qiuyu Liu · 2022 · Genes
67. The effects of MYC on tumor immunity and immunotherapy
    Jiajin Li, Tingyu Dong, Zhen Wu, Dacheng Zhu, Hao Gu · 2023 · Cell Death Discovery
68. MYC oncogene in myeloid neoplasias
    M. Dolores Delgado, Marta Albajar, María Teresa Gómez‐Casares, Ana Batlle, Javier León · 2012 · Clinical & Translational Oncology
69. Genome-wide profiling of long noncoding ribonucleic acid expression patterns in ovarian endometriosis by microarray
    Peng-ran Sun, Shuangzheng Jia, Hong Lin, Jinhua Leng, Jinghe Lang · 2014 · Fertility and Sterility
70. Myc increases self-renewal in neural progenitor cells through Miz-1
    Laura Kerosuo, Katja M. Piltti, Heli Fox, Alexandre Angers‐Loustau, Valtteri Häyry, Martin Eilers, Hannu V. Sariola, Kirmo Wartiovaara · 2008 · Journal of Cell Science
71. S-Adenosyl Homocysteine Hydrolase Is Required for Myc-Induced mRNA Cap Methylation, Protein Synthesis, and Cell Proliferation
    María Elena Fernández-Sánchez, Thomas Gonatopoulos-Pournatzis, G Preston, Margaret A. Lawlor, Victoria H. Cowling · 2009 · Molecular and Cellular Biology
72. Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells
    Harshil Dhruv, Wendy S. McDonough Winslow, Brock A. Armstrong, Serdar Tuncali, Jenny M. Eschbacher, Kerri L. Kislin, Joseph C. Loftus, Nhan L. Tran, Michael E. Berens · 2013 · PLoS ONE
73. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib
    Albajar, Marta, Gómez-Casares, M. Teresa, Llorca, Javier, Mauleon, Itsaso, Vaqué, Jose P., Acosta, Juan C., Bermúdez, Arancha, Donato, Nicholas, Delgado, M. Dolores, León, Javier · 2011 · Molecular Cancer Research
74. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable
    Daniel Jeffrey Landsburg, Marissa K. Falkiewicz, Adam Matthew Petrich, Benjamin A. Chu, Amir Behdad, Shaoying Li, Leonard Jeffrey Medeiros, Ryan Daniel Cassaday, Nishitha M Reddy, Martin A. Bast et al. · 2016 · British Journal of Haematology
75. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78
    Chenxue Gong, Xiao Hu, Yingling Xu, Jinhuan Yang, Lei Zong, Cui Wang, Ji Jun Zhu, Zhuoyu Li, De-zhao Lu · 2019 · Anti-Cancer Drugs
76. Long non-coding RNA CCAT1 that can be activated by c-Myc promotes pancreatic cancer cell proliferation and migration.
    Qiuyun Yu, Xinfeng Zhou, Qing Xia, Jia Shen, Yan Jia, Jiu‐Ting Zhu, Xiang Li, Ming Shu · 2016 · PubMed Central
77. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation
    Victoria H. Cowling, Michael D. Cole · 2006 · Oncogene
78. Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
    Tian Liu, Shangcong Han, Yu Yao, Guiming Zhang · 2023 · Cancer Management and Research
79. C-Myc Is a Critical Mediator of the Phenotypes of Apc Loss in the Intestine
    Julie A. Wilkins, Owen James Sansom · 2008 · Cancer Research
80. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas
    Wenting Huang, Leonard Jeffrey Medeiros, Pei Lin, Wei Wang, Guilin Tang, Joseph David Khoury, Sergej Naumovich Konoplev, C. Cameron Yin, Jie Xu, Yasuhiro Oki et al. · 2018 · Modern Pathology
81. Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
    S. Yiu, Mike Dorothea, K. Hui, A. Chiang · 2020 · Cancers
82. Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth
    Le Sun, Yu Yan, Heng Lu, Jianlong Li, Zhiyuan Wang, Kun Wang, Lin Wang, Yunxia Li, Hong Jiang, Yaoyang Zhang · 2021 · Cell chemical biology
83. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
    Raymond S. Traweek, Brandon M. Cope, Christina Lynn Roland, Emily Zhi-Yun Keung, Elise F. Nassif, Derek J. Erstad · 2022 · Frontiers in Oncology
84. MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1
    María Teresa Gómez‐Casares, E García-Alegria, C E López-Jorge, Nuria Ferrándiz, R Blanco, S Alvarez, Jose Pedro Vaque, Gabriel Bretones, J M Caraballo, María Pilar Sánchez-Bailón et al. · 2012 · Oncogene
85. MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib
    Federico Cappuzzo, Marileila Varella‐Garcia, Elisa Rossi, Sujatha Gajapathy, Marialuisa Valente, Harry A. Drabkin, Robert M. Gemmill · 2009 · Journal of Thoracic Oncology
86. The Molecular Mechanism of Induced Pluripotency: A Two-Stage Switch
    Wouter Scheper, Sjef C.V.M. Copray · 2009 · Stem Cell Reviews and Reports
87. DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt’s lymphoma
    Candace J. Poole, Wenli Zheng, Atul Lodh, Aleksey Yevtodiyenko, Daniel F. Liefwalker, Honglin Li, Dean W. Felsher, Jan van Riggelen · 2017 · Oncotarget
88. Elevation of c-MYC Disrupts HLA Class II–Mediated Immune Recognition of Human B Cell Tumors
    Jason M. God, Christine A. Cameron, Janette Figueroa, Shereen Amria, Azim Hossain, Bettina Kempkes, Georg W. Bornkamm, Robert Kenneth Stuart, Janice S. Blum, Azizul Haque · 2015 · The Journal of Immunology
89. Crucial Role of C-Myc in the Generation of Induced Pluripotent Stem Cells
    Ryoko Araki, Yuko Hoki, Masahiro Uda, Miki Nakamura, Yuko Jincho, Chihiro Tamura, Misato Sunayama, Shunsuke Ando, Mayumi Sugiura, Mitsuaki A. Yoshida et al. · 2011 · Stem Cells
90. Mantle Cell Lymphoma With MYC Rearrangement
    Zhihong Hu, Leonard Jeffrey Medeiros, Zi Chen, Weina Chen, Shaoying Li, Sergej Naumovich Konoplev, Xinyan Y. Lu, Lan V. Pham, Ken H. Young, Wei Wang et al. · 2016 · The American Journal of Surgical Pathology
91. Deciphering the roles of lncRNAs in breast development and disease
    John Lalith Charles Richard, Pieter J.A. Eichhorn · 2018 · Oncotarget
92. Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells
    Salah Boudjadi, Julie C. Carrier, J-F Groulx, Jean‐François Beaulieu · 2015 · Oncogene
93. lncRNAs and MYC: An Intricate Relationship
    Ingram Iaccarino · 2017 · International Journal of Molecular Sciences
94. Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest
    Juan Carlos Acosta, Nuria Ferrándiz, Gabriel Bretones, Verónica Torrano, Rosa E. Blanco, Carlos Richard, Brenda C O’Connell, John M. Sedivy, M. Dolores Delgado, Javier León · 2008 · Molecular and Cellular Biology
95. Targeting MYC-Regulated miRNAs to Combat Cancer
    Anna Frenzel, Jakob Lovén, Marie Arsenian‐Henriksson · 2010 · Genes & Cancer
96. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis
    Shaoying Li, Vivian Lee Weiss, Xuan J. Wang, Parth Anil Desai, Shimin Hu, C. Cameron Yin, Guilin Tang, Nishitha M Reddy, Leonard Jeffrey Medeiros, Pei Lin · 2015 · The American Journal of Surgical Pathology
97. Progress Report on “From Printed Electrolyte‐Gated Metal‐Oxide Devices to Circuits”
    Gabriel Cadilha Marques, Dennis D. Weller, Ahmet Turan Erozan, Xiaowei Feng, Mehdi Baradaran Tahoori, Jasmin Aghassi‐Hagmann · 2019 · Advanced Materials
98. BET inhibition as a new strategy for the treatment of gastric cancer
    Raquel Carvalho Montenegro, Peter G. K. Clark, Alison Howarth, Xiao Wan, Alessandro Ceroni, Paulina Siejka, Graciela A. Nunez-Alonso, Octovia Monteiro, Catherine M. Rogers, Vicki Gamble et al. · 2016 · Oncotarget
99. Physiological functions of FBW7 in cancer and metabolism
    Kouhei Shimizu, Naoe Taira Nihira, Hiroyuki Inuzuka, Wenyi Wei · 2018 · Cellular Signalling
100. Myc coordinates transcription and translation to enhance transformation and suppress invasiveness
     Ran Elkon, Fabricio Loayza‐Puch, Gözde Korkmaz, Rui Lopes, Pieter C. Van Breugel, Onno B. Bleijerveld, Maarten A. F. Altelaar, Elmar Wolf, Francesca Lorenzin, Martin Eilers et al. · 2015 · EMBO Reports